EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND OF BENEFICIAL INTEREST
Aktie · US2772531008 (XNYS)
AI-gestützte Analyse
Fundamental-Analyse
Was die Zahlen wirklich bedeuten – bevor der Markt es weiß.
Jetzt analysieren
News Sentiment
Kaufchance oder Alarmsignal? Was die aktuellen Nachrichten wirklich bedeuten.
Jetzt analysieren
Kaufen / Halten / Verkaufen
Kaufen, Halten oder Verkaufen? Das AI-Urteil auf einen Blick.
Jetzt analysieren
Risiko-Bewertung
Risiken erkennen, bevor sie zum Problem werden.
Jetzt analysieren
Fair Value
Zu teuer, fair bewertet oder ein Schnäppchen?
Jetzt analysieren
Neuste KI Analysen zu EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND OF BENEFICIAL INTEREST
Kein Kurs
28.04.2026 20:00
Aktuelle Kurse von EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND OF BENEFICIAL INTEREST
| Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung |
|---|---|---|---|---|---|
UTC |
ETBI
|
USD
|
28.04.2026 20:00
|
0,001 USD
| 0,00 USD |
Firmenprofil zu EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND OF BENEFICIAL INTEREST Aktie
EastGate Biotech Corp. is a pharmaceutical company. The Company produces and distributes nutraceuticals that are based on natural therapies and absorbed naturally by the body. It utilizes state-of-the-art nanotechnologies to deliver healthy alternatives to conventional pharmaceuticals that all too often create dangerous side effects and unexpected consequences for those trying to attain and maintain healthy lives. The Company’s products include E-Drops NANO, Essential D, GluCora, VCleanzz, Cleanezze and Warts X. The Company develops products in which the components are incorporated into vehicles containing nano-sized delivery vectors, including oil droplets (nanoemulsions), polymeric particles (nanoparticles) and the combination of polymers and lipids with surfactants (hybrid nanoparticles, nanocapsules, mixed micelles). It has its offices in New York, London SF, Cockfosters BP, Los Angeles, Chicago and Las Vegas.
Unternehmensdaten
Name EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND OF BENEFICIAL INTEREST
Firma Eastgate Biotech Corp.
Website
www.EastGateBiotech.com
Heimatbörse
NYSE
NYSE
ISIN US2772531008
Wertpapierart Aktie
Sektor Healthcare
Branche Medical - Pharmaceuticals
CEO Rosella C. Perri
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,0 T
Adresse 65 Harbour Square Suite 2203Toronto, M5J 2L4Canada, Toronto
IPO Datum 2014-03-05
Ticker Symbole
| Name | Symbol |
|---|---|
| Over The Counter | ETBI |
Weitere Aktien
Investoren, die EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND OF BENEFICIAL INTEREST halten, haben auch folgende Aktien im Depot:
